Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Cetuximab.

Client Email

Product

Cetuximab
HEALTH CANADA PATENTS

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Cetuximab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 2 JDMF, 2 Listed Suppliers

4 API Suppliers
2 JDMF
2 Listed Suppliers

DEVELOPMENTS

55 Drugs in Development

55 Drugs in Development

FINISHED DOSAGE FORMULATIONS

37 FDF Dossiers, 1 FDA Orange Book, 5 Europe, 1 Canada, 28 Australia, 2 South Africa

37 FDF Dossiers
1 FDA Orange Book
5 Europe
1 Canada
28 Australia
2 South Africa

RELATED EXCIPIENT COMPANIES

3 Actylis

3 Actylis

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 84 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
84 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices, 12 Annual Reports

1 US Medicaid Prescriptions
3 Finished Drug Prices
12 Annual Reports

MARKET PLACE

2 APIs, 4 FDF Dossiers

2 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Gowling Lafleur Henderson LLP

filter Patent Reset all filters

1 All

01 11340417

filter Product Reset all filters

1 All

01 1Cetuximab

filter Dosage Reset all filters

1 All

01 1Solution

filter Exp Date Reset all filters

1 All

01 12016-03-02

Product Main Page

01

Gowling Lafleur Henderson LLP

Cetuximab

Discovery on Target

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

Discovery on Target

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2016-03-02

Date Granted : 1999-03-02

Brand Name : ERBITUX

Patent Number : 1340417

Filing Date : 1989-09-13

Strength per Unit : 2 mg / mL

Dosage Form : Solution

Human Or VET : Human

Route of Administration : Intravenous Injection

Patent Expiration Date : 2016-03-02

Date Granted : 1999-03-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?